Literature DB >> 2547902

Regulatory properties of calcium/calmodulin-dependent protein kinase II in rat brain postsynaptic densities.

D P Rich1, R J Colbran, C M Schworer, T R Soderling.   

Abstract

Calcium/calmodulin (CaM)-dependent protein kinase II (CaM-kinase II) contained within the postsynaptic density (PSD) was shown to become partially Ca2+-independent following initial activation by Ca2+/CaM. Generation of this Ca2+-independent species was dependent upon autophosphorylation of both subunits of the enzyme in the presence of Mg2+/ATP/Ca2+/CaM and attained a maximal value of 74 +/- 5% of the total activity within 1-2 min. Subsequent to the generation of this partially Ca2+-independent form of PSD CaM-kinase II, addition of EGTA to the autophosphorylation reaction resulted in further stimulation of 32PO4 incorporation into both kinase subunits and a loss of stimulation of the kinase by Ca2+/CaM. Examination of the sites of Ca2+-dependent autophosphorylation by phosphoamino acid analysis and peptide mapping of both kinase subunits suggested that phosphorylation of Thr286/287 of the alpha- and beta-subunits, respectively, may be responsible for the transition of PSD CaM-kinase II to the Ca2+-independent species. A synthetic peptide 281-309 corresponding to a portion of the regulatory domain (residues 281-314) of the soluble kinase inhibited syntide-2 phosphorylation by the Ca2+-independent form of PSD CaM-kinase II (IC50 = 3.6 +/- 0.8 microM). Binding of Ca2+/CaM to peptide 281-309 abolished its inhibitory property. Phosphorylation of Thr286 in peptide 281-309 also decreased its inhibitory potency. These data suggest that CaM-kinase II in the PSD possesses regulatory properties and mechanisms of activation similar to the cytosolic form of CaM-kinase II.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2547902     DOI: 10.1111/j.1471-4159.1989.tb11777.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Differential roles of Ca(2+)/calmodulin-dependent protein kinase II and mitogen-activated protein kinase activation in hippocampal long-term potentiation.

Authors:  J Liu; K Fukunaga; H Yamamoto; K Nishi; E Miyamoto
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

2.  Ca(2+)-independent autophosphorylation of postsynaptic density-associated Ca2+/calmodulin-dependent protein kinase.

Authors:  A Dosemeci; C Choi
Journal:  Neurochem Res       Date:  1997-09       Impact factor: 3.996

3.  Possible role for calmodulin and the Ca2+/calmodulin-dependent protein kinase II in postsynaptic neurotransmission.

Authors:  P Siekevitz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

Review 4.  Multifunctional Ca2+/calmodulin-dependent protein kinase.

Authors:  H Schulman; P I Hanson
Journal:  Neurochem Res       Date:  1993-01       Impact factor: 3.996

Review 5.  Calcium/calmodulin-dependent protein kinase II: role in learning and memory.

Authors:  T R Soderling
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

6.  Mitogen-activated protein kinase regulates early phosphorylation and delayed expression of Ca2+/calmodulin-dependent protein kinase II in long-term potentiation.

Authors:  M G Giovannini; R D Blitzer; T Wong; K Asoma; P Tsokas; J H Morrison; R Iyengar; E M Landau
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  A structural mechanism for maintaining the 'on-state' of the CaMKII memory switch in the post-synaptic density.

Authors:  Praseeda Mullasseril; Ayse Dosemeci; John E Lisman; Leslie C Griffith
Journal:  J Neurochem       Date:  2007-10       Impact factor: 5.372

8.  Herbal formula GAPT prevents beta amyloid deposition induced Ca(2+)/Calmodulin-dependent protein kinase II and Ca(2+)/Calmodulin-dependent protein phosphatase 2B imbalance in APPV717I mice.

Authors:  Jing Shi; Xuekai Zhang; Long Yin; Mingqing Wei; Jingnian Ni; Ting Li; Pengwen Wang; Jinzhou Tian; Yongyan Wang
Journal:  BMC Complement Altern Med       Date:  2016-06-01       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.